Bright Minds Biosciences toPresent at Upcoming Conferences
October 30, 2025 18:30 ET Â | Source: Bright Minds Biosciences NEW YORK,…
authID to Report Third Quarter 2025 Financial Results on November 12, 2025
DENVER, Oct. 29, 2025 (GLOBE NEWSWIRE) -- authID® (Nasdaq: AUID) (“authID” or…
PJT Partners Inc. to Report Third Quarter and Nine Months 2025 Financial Results and Host a Conference Call on November 4, 2025
NEW YORK--(BUSINESS WIRE)--PJT Partners Inc. (“PJT Partners”) (NYSE:PJT) announced that it expects…
NTG Nordic Transport Group A/S – Q3 2025 Conference Call
October 10, 2025 04:00 ET Â | Source: NTG Nordic Transport Group A/S…
Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX),…
Upstream Bio to Host Conference Call and Webcast to Report Top-Line Data from the Phase 2 VIBRANT Trial of Verekitug in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
WALTHAM, Mass., Sept. 01, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq:…
Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine
Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint…
SAP Executives to Participate in Upcoming Investor Events in Q3 2025
WALLDORF, Germany, Aug. 26, 2025 /PRNewswire/ -- SAP SE (NYSE: SAP) today…
Zelluna ASA Reports Second Quarter 2025 Financial Results and Provides General Business Update
Oslo, Norway, 20 August 2025 – Zelluna (OSE: ZLNA), a company pioneering…
Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call
August 13, 2025 11:45 ET Â | Source: Milestone Scientific, Inc. ROSELAND, N.J.,…